Wet Age-Related Macular Degeneration – A Serious Form of Eye Disease

Retina Associates

Retina Associates

Serving the needs of Tucson, Arizona, patients, Dr. Cameron Javid and the Retina Associates team provide advanced ophthalmologic care for a variety of eye conditions. Among the conditions for which Retina Associates offers exceptionally high-quality treatment is age-related macular degeneration (AMD), which stands as the most common cause of vision loss worldwide in people over 60 years of age.

A condition centering on the gradual breakdown of the macula within the retina, macular degeneration impacts the patient’s ability to clearly make out details. The two basic types of the condition are dry, non-exudative AMD, and exudative, wet AMD. The latter form of AMD results in more severe visual impairment and accounts for the vast majority of blindness incidents associated with the disease.

Composed of a complex cellular network, the retina stands as one of the body’s most metabolically active tissues. The tissue receives its oxygen and nutrient supply through blood vessels in the retina and choroid layers that enable high blood flow. This process can be disrupted through problems with vascular endothelial growth factor (VEGF), which can lead to abnormal growth of blood vessels in the eye as well as hemorrhaging and edema beneath the macula. As these lesions turn into scars, the macula is destroyed and central vision deteriorates rapidly.

Reflecting its seriousness, cases of wet AMD require immediate treatment that includes the use of VEGF inhibitors as a way of shutting down the choroidal neovascularization process. In addition, several clinical trials are available with new treatment options for patients that qualify.

Branch Retinal Vein Occlusion – An Eye Blockage Impacting Vision

Retina Associates pic

Retina Associates
Image: retinatucson.com

With a team of respected Tucson, Arizona, medical professionals, Retina Associates offers quality care for a range of conditions requiring ophthalmologic treatment. Among the areas of focus for Cameron Javid, MD, and Retina Associates are central and branch retinal vein occlusions (CRVO and BRVO).

Retinal vein occlusions involve situations in which the veins that carry nutrient and oxygen-rich blood from the retina’s nerve cells are obstructed. If the blockage involves the main vein, the condition is known as CRVO and if it involves smaller veins, it is called BRVO.

The latter typically occur at arteriovenous crossings, which are situated at the intersection between the vein and retinal artery. The artery hardens in a process of atherosclerosis within a sheath shared with the smaller veins. Losing flexibility and becoming compressed, the restricted blood flow can lead to clotting and occlusion. When the blood cannot drain it can also leak into the macular edema at the center of vision.

Not a curable condition, treatment of BRVO aims at maintaining vision stability, and typically involves intraocular injections of medicine. There are currently 4 medications to choose from or laser treatment. We are currently recruiting patients for the TOPAZ cilincal trial which utilizes a new way to administer a steroid to the eye yo reduce swelling of the macula which is the central retina.

Retinal Detachment – A Serious Issue Associated with Aging


Understanding the Eye Disease Uveitis